Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Shanghai Ennova Biopharmaceutical identifies new TRK inhibitors

May 5, 2020

Takeda Pharmaceutical synthesizes mTOR inhibitors

May 5, 2020

Eli Lilly and Company patents new KRAS G12C inhibitors

May 5, 2020

Evaluating the clinical significance of KIAA1199 expression in locally advanced gastric cancer

May 5, 2020

IPN-60090: a GLS1 inhibitor for the oral treatment of KEAP1/NFE2L2-mutant NSCLC and ASNS-low HGSOC

May 4, 2020

Preclinical and preliminary phase I results presented for menin/MLL interaction inhibitor SNDX-5613

May 4, 2020

Medshine Discovery divulges new GLS1 inhibitors

May 4, 2020

Morphic Therapeutic synthesizes integrin alphavbeta6 antagonists

May 4, 2020

Novartis presents preclinical data for TNO-155

May 4, 2020

Discovery of a novel highly potent and orally active EED inhibitor

May 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...